IRIS International (IRIS)


"IRIS International, Inc. is a leader in in vitro diagnostic urinalysis systems, digital imaging software development, sample collection, sample processing and small benchtop centrifuges and supplies for chemistry, coagulation, cytology, hematology, and urinalysis for the clinical and veterinary markets. The Company operates through its Iris Diagnostics division, and two subsidiaries: Iris Sample Processing (formerly Statspin®) and Advanced Digital Imaging Research, LLC (ADIR)." (company website)

IRIS 3-month stock chart


IRIS has been bouncing around testing support at the 200-day moving average. The price has gone up quite a bit since the last EPS report, and was recently boosted by news of a large order. If it can hold the current level, I think it can move up.

  • Price momentum (PPO) — slowed down since boost over news
  • Trend (ADX) — still above the threshhold and selling pressure (-DI) is ebbing in last couple of days
  • Money flow (CMF) — reasonably strong inflow
  • Relative strength (RSI) — dipped just below neutral, but increasing again now
  • Volume — fairly lightly traded, but average volume is up compared to three months ago

Based on technical analysis, MarketEdge calls IRIS a "buy" in a "strong upward trend."


gain Bottom line

I decided to sell IRIS today, even though it is above my stop. Since jumping up at the beginning February, it has moved steadily downward. The upper Bollinger band is moving down, as is the one-month moving average. There are other signs of growing deterioration in the chart: momentum (PPO) has stalled; the trend (ADX) is weakening; inflow of money (CMF) is withering away; and relative strength (RSI) has dipped. Despite all that, MarketEdge is still calling IRIS a "strong buy" in a "strong upward trend." I'm agnostic.